Hypsarrhythmia assessment exhibits poor interrater reliability: A threat to clinical trial validity
Lists
Only you see this
Abstract
This study contradicts the view that hypsarrhythmia assessment is straightforward. Even small variability in the identification of hypsarrhythmia has potentially deleterious consequences for clinical care, as its presence or absence impacts decisions to pursue high-risk and high-cost therapies. These inconsistencies may similarly confound studies in which abolition of hypsarrhythmia is an outcome measure. There is a great need for practical, reliable, and unbiased measures of hypsarrhythmia.
BibTeX
@inproceedings{hussain2014hypsarrhythmia,
author = {Shaun A. Hussain and Grace Kwong and J Gordon Millichap and John R. Mytinger and Nicole Ryan and Joyce H. Matsumoto and Joyce Y. Wu and Jason T. Lerner and Raman Sankar},
title = {{Hypsarrhythmia assessment exhibits poor interrater reliability: A threat to clinical trial validity}},
booktitle = {Epilepsia},
year = {2014},
doi = {10.1111/epi.12861},
}Loading related content...